PCSK9: The promise of a new target in lipid management
Prof. John E Deanfield, UCL, London
10' education - Sep. 3, 2014 - Barcelona, ESC - Prof. John E Deanfield, UCL, LondonProf. John E Deanfield, London introducing the rationale for PCSK9 inhibition with a lecture held during the EBAC accredited symposium on innovations in lipid management at ESC 2014 in Barcelona
Educational information
The educational programme at ESC was CME accredited by EBAC.
This online session is not accredited, but similar in content
The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.
Share this page with your colleagues and friends: